Olympic snowboarder turned cartel cocaine kingpin wanted by FBI for ordering execution



A former Olympic snowboarder is on the FBI Most Wanted List for allegedly spearheading a multicultural trafficking organization.

Ryan James Wedding is a 44-year-old former snowboarder from Thunder Bay, Ontario, Canada, who competed at the 2002 Winter Olympics in Salt Lake City. He took part in the men's Parallel Giant Slalom for Canada, finishing 24th.

However, that would seemingly be the last time Wedding dealt with literal snow before becoming an accused cocaine trafficker.

'Ryan Wedding controls one of the most prolific and violent drug trafficking organizations in this world.'

According to Sporting News, Wedding's first drug charges came six years after his Olympics appearance, when he was arrested in San Diego for cocaine trafficking and later convicted for conspiracy to possess and distribute.

Now, the FBI has placed Wedding on its top 10 most-wanted list and, working with the Department of Justice and Royal Canadian Mounted Police, has charged him with overseeing the operations of a criminal enterprise, engaging in witness intimidation, and profiting off of laundered drug money.

Wedding is believed to be in Mexico, where he is currently being sheltered by cartel associates.

Attorney General Pam Bondi said, "Ryan Wedding controls one of the most prolific and violent drug trafficking organizations in this world and works closely with the Sinaloa Cartel."

She added, "We will not rest until his name is taken off the FBI's Top 10 Most Wanted List, and his narco-trafficking organization lies dismantled."

Details of Wedding's witness intimidation came from the DOJ, which said he ordered a hit on a witness in a federal narcotics case.

RELATED: Police walked right past DNC pipe bomb to first look under a bush where bomber sat 17 hours earlier

Wedding allegedly placed a bounty on the head of a witness for a 2024 indictment and enlisted others to locate and kill him. The witness was shot to death in a restaurant in Medellin, Colombia.

Not only is Wedding said to have ordered the assassinations of others as well, but perhaps shockingly, it was allegedly Wedding's lawyer who advised him to put out the hit on the 2024 witness.

Deepak Balwant Paradkar, a 62-year-old barrister residing in Thornhill, Ontario, Canada, allegedly advised Wedding to murder the victim in order to avoid extradition to the United States from Mexico. Paradkar also improperly provided Wedding with court documents and access to members of his enterprise who had been arrested.

Wedding is charged with a multitude of crimes stemming from the 2024 indictment, including continuing criminal enterprise, assorted drug trafficking charges, and directing the murder of two members of a family from Caledon, Ontario, Canada, in November 2023.

Those killings were reportedly in retaliation for a stolen drug shipment in California. A third family member was also shot but survived the injuries.

RELATED: LeBron James' closest allies now in the spotlight for shocking NBA gambling probe

Photo by Andrew Harnik/Getty Images

"Ryan Wedding and his associates allegedly imported tons of cocaine each year from Colombia through Mexico and onto the streets of U.S. communities," FBI Director Kash Patel said. "His criminal activities and violent actions will not be tolerated, and this is a clear signal that the FBI will use our resources and expertise to find Ryan Wedding and bring him and his associates to justice."

The diverse cast of characters involved in the case included Edwin Basora-Hernandez, a reggaeton musician from the Dominican Republic, who provided the contact information for the aforementioned witness, which helped assassins locate him.

Gursewak Singh Bal, co-founder of the Dirty News website, allegedly took money in exchange for not posting about Wedding, and instead posting a photograph of the aforementioned witness.

A $15 million reward for information leading to Wedding's arrest or prosecution was issued by the U.S. government, with another $2 million in reward money offered for similar information on each of the assassins.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Most Women Are On Crazy Pills, And It’s Bad For Everyone

An entire generation of women is lost amidst engineered anxiety, chasing hollow independence while forsaking the proven anchors of marriage, family, and selfless purpose.

Trump strikes major deal with pharma giants Lilly and Novo over obesity drugs, Medicare



Health and Human Services Secretary Robert F. Kennedy Jr. is working on identifying and tackling the root causes of America's obesity epidemic. In the meantime, the Trump administration wants to make sure that Americans have access to affordable diabetes and weight-loss drugs, specifically glucagon-like peptide-1 receptor agonists, better known as GLP-1 drugs.

To this end and as part of his months-long campaign to bring most-favored-nation prescription drug pricing to Americans, President Donald Trump has struck a deal with pharmaceutical giants Eli Lilly and Novo Nordisk, the manufacturer of Ozempic, to cut prices on their weight-loss drugs in exchange for Medicare coverage.

A senior administration official indicated on Thursday that since Trump issued his most-favored-nation pricing executive order in May, GLP-1 drugs "have been top of mind" — not just because of the pharmaceuticals' apparent cardiometabolic benefits "but also because this is, again, an issue of fairness."

RELATED: How MAHA can really save American lives

IM WATSON/AFP via Getty Images

Per the terms of Trump's deal with the two companies, "starting oral doses of GLP-1s will cost just $149 for everyone on Medicare, Medicaid, or Trump Rx," said an official. "That's roughly 1/9th of today's list price."

For Medicare, the manufacturers have reportedly agreed to reduce prices on GLP-1 drugs that are currently used for diabetes and other covered conditions to $245 per month across all other doses, added the official.

Savings generated by these price reductions will apparently be used to provide new coverage for GLP-1 drugs to patients struggling with obesity who face high metabolic or cardiovascular risk at the same monthly cost of $245.

As of 2020, over 100 million American adults were obese, and more than 22 million adults suffered from severe obesity, according to the Centers for Disease Control and Prevention.

While the adult obesity rate reportedly declined from 39.9% in 2022 to 37% this year — representing roughly 7.6 million fewer obese adults — Gallup recently indicated that diagnoses of diabetes have reached an all-time high of 13.8%.

Amid the glut of diabetes cases, there has been a significant increase in the number of U.S. adults who report taking GLP-1 drugs — from 5.8% in February 2024 to 12.4% in the latest quarter of 2025. The three-year decline in obesity among most age groups appears to correspond with the embrace of the weight-loss drugs.

When asked roughly how many patients on Medicare and Medicaid would be impacted by these changes, another administration official noted that in Medicare, around 10% of the population will be eligible for the standard access. While the drugs are approved for a much broader population, access has been constrained for "patients that will benefit clinically from it."

There will reportedly be three tiers of patients in Medicare who will have access to these drugs for the purposes of addressing obesity and driving "cardiometabolic improvement": those with a body mass index greater than 27 kg/m² suffering from pre-diabetes or established cardiovascular disease; patients with a BMI greater than 30 who have uncontrolled hypertension, kidney disease, and/or heart failure; and individuals with a BMI exceeding 35.

'We do not believe that GLP-1s or drugs alone are somehow some silver bullet.'

"This is about making America healthy again," said the second official. "This is about preventing strokes, this is about preventing heart attacks, and this is about preventing end-stage renal disease."

The officials acknowledged, however, that cheaper drugs do not amount to a long-term solution to the problem of obesity.

"Make no mistake: We're in a war against obesity. We do not believe that GLP-1s or drugs alone are somehow some silver bullet to make the ... country healthy again," said one official. "They are an important jump-start."

In exchange for their cooperation, the pharma giants are gaining additional access to beneficiaries who wouldn't otherwise be covered by Medicare for obesity indications, certainty from the Trump administration on its approach to drug pricing moving forward, and a commitment to invest in American manufacturing.

One Trump administration official told reporters that this initiative is expected to ultimately be cost neutral, stating, "This is really a win-win on all sides — for taxpayers, for Medicare beneficiaries, as well as for the companies."

Last month, Trump announced an agreement with AstraZeneca that would guarantee every state Medicaid program across the country most-favored-nation drug prices on the pharma giant's products. The previous month, he announced a similar deal with Pfizer.

"In case after case, our citizens pay massively higher prices than other nations pay for the same exact pill, from the same factory, effectively subsidizing socialism [abroad] with skyrocketing prices at home," Trump said in a statement. "So we would spend tremendous amounts of money in order to provide inexpensive drugs to another country. And when I say the price is different, you can see some examples where the price is beyond anything — four times, five times different."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Pfizer COVID shot sales plummet after Trump administration ends universal recommendations



U.S. sales of Pfizer's Comirnaty shots have taken a nosedive since the Trump administration updated its immunization schedules last month and dropped the universal collective recommendations for COVID-19 vaccines.

The pharmaceutical company's revenues for the third quarter of 2025 are down 6% — amounting to a $1 billion drop — compared to the same stretch the previous year.

'CDC's 2022 blanket recommendation for perpetual COVID-19 boosters deterred health care providers from talking about the risks.'

Pfizer indicated in its latest earnings statement that "the operational decrease was primarily driven by a year-over-year decline in COVID-19 product revenues largely due to lower infection rates impacting Paxlovid demand as well as a narrower vaccine recommendation for COVID-19 in the U.S. that reduced the eligible population for Comirnaty."

Sales of Comirnaty were down 25% in the United States, and sales of Paxlovid, an oral antiviral medication that treats mild-to-moderate COVID-19 in adults, were down 52%.

When his agency dropped the universal recommendation last month for Comirnaty — a controversial vaccine used at a time of population-wide immunity to treat an endemic virus fatal in roughly 1% of confirmed cases — Centers for Disease Control and Prevention Acting Director Jim O'Neill stated, "CDC's 2022 blanket recommendation for perpetual COVID-19 boosters deterred health care providers from talking about the risks and benefits of vaccination for the individual patient or parent. That changes today."

RELATED: Naomi Wolf continues to expose COVID vaccine: 'A depopulating technology'

Photo by PATRICK T. FALLON/AFP via Getty Images

The CDC's decision came just months after the U.S. Food and Drug Administration forced Pfizer to slap a damning warning on its Comirnaty vaccine noting the estimated unadjusted incidence of heart conditions following administration of the 2023-2024 formula of the shot, as well as the longitudinal results of a 2024 study concerning cardiac manifestations and outcomes of vaccine-associated myocarditis in American youths.

The FDA also required Pfizer to describe the new safety information in the adverse reactions section of its vaccine information insert such that it now notes that "the estimated unadjusted incidence of myocarditis and/or pericarditis during the period 1 through 7 days following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines was approximately 8 cases per million doses in individuals 6 months through 64 years of age and approximately 27 cases per million doses in males 12 through 24 years of age."

While the FDA has approved the drug for use in individuals who are 65 years of age and older or 5-64 years old who suffer from at least one underlying condition putting them at high risk for severe outcomes from COVID-19, it revoked the emergency use authorization for the shot in August.

Pfizer CEO Albert Bourla reportedly suggested on a Tuesday call with analysts that the company is looking for opportunities outside the United States, stating that the company's catalog of vaccines constitute a "key area of focus in international markets."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Idiot Media Ignore 40 Years Of History To Pretend Trump Attacks On Cartels Are Unprecedented

Right or wrong, Trump isn’t doing anything new with these choices, which are all well within the range of long-established political norms.

Scarface of Springfield: Massachusetts Governor's Senior Staffer Arrested for Drug Trafficking

Authorities have arrested a senior staffer to Massachusetts Democratic governor Maura Healey on drug trafficking charges following a sting operation at a government building.

The post Scarface of Springfield: Massachusetts Governor's Senior Staffer Arrested for Drug Trafficking appeared first on .

Hegseth announces more lethal boat strikes to eradicate drug traffickers



The Trump administration performed strikes in international waters in the eastern Pacific on Monday to stop several boats carrying illegal narcotics, according to Secretary of War Pete Hegseth.

'We will track them, we will network them, and then, we will hunt and kill them.'

He announced on Tuesday the results of "three lethal kinetic strikes on four vessels," claiming that they were operated by "Designated Terrorist Organizations."

In January, President Donald Trump designated international cartels as foreign terrorist organizations for flooding the U.S. with "deadly drugs, violent criminals, and vicious gangs."

Monday's strikes killed 14 narco-terrorists, Hegseth said. No U.S. forces were harmed.

"Eight male narco-terrorists were aboard the vessels during the first strike. Four male narco-terrorists were aboard the vessel during the second strike. Three male narco-terrorists were aboard the vessel during the third strike," he explained. "The Department has spent over TWO DECADES defending other homelands. Now, we're defending our own. These narco-terrorists have killed more Americans than Al-Qaeda, and they will be treated the same. We will track them, we will network them, and then, we will hunt and kill them."

Hegseth noted that there was one survivor.

"Regarding the survivor, USSOUTHCOM immediately initiated Search and Rescue (SAR) standard protocols; Mexican SAR authorities accepted the case and assumed responsibility for coordinating the rescue," he added.

RELATED: 'We will stop you cold': Trump announces successful strike against 'narcoterrorist' vessel

Pete Hegseth. Photo by Andrew Harnik/Getty Images

Mexican President Claudia Sheinbaum on Tuesday condemned the most recent strikes.

"We do not agree with these attacks, with how they are carried out," Sheinbaum stated. "We want all international treaties to be complied with."

RELATED: Trump’s Caribbean ‘drug wars’ are forging a new Monroe Doctrine

Photographer: Will Oliver/EPA/Bloomberg via Getty Images

A separate strike was carried out at President Donald Trump's direction in the Caribbean Sea last week against a vessel reportedly operated by Tren de Aragua.

"The vessel was known by our intelligence to be involved in illicit narcotics smuggling, was transiting along a known narco-trafficking route, and carrying narcotics," Hegseth stated on Friday. "Six male narco-terrorists were aboard the vessel during the strike, which was conducted in international waters — and was the first strike at night. All six terrorists were killed, and no U.S. forces were harmed in this strike."

The U.S. has performed more than a dozen strikes since September. At least 57 people have been killed, according to the Associated Press.

— (@)

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Tylenol fights autism claims, slams proposed FDA warning label as 'unsupported' by science



The maker of Tylenol is fighting back against proposed changes to its label.

Kenvue, the American company behind Tylenol, says changes proposed by a recent petition would be "improper."

'Fight like hell not to take it.'

After the Trump administration linked the use of Tylenol during pregnancy to autism, the Informed Consent Action Network urged the FDA to "change the labels" for Tylenol and provide "crucial warnings for pregnant women and their care providers."

No evidence for risk?

Kenvue responded directly to the petition in its own document and said that changing the labeling to its over-the-counter acetaminophen products in such a manner would be "unsupported by the scientific evidence and legally and procedurally improper."

Requesting that the consumer-facing warning addresses a risk between "acetaminophen use and neurodevelopmental disorders" would allegedly go against the "overwhelming weight of the evidence contradicts the existence of any such risk," Kenvue claimed.

The manufacturer called acetaminophen one of the "most studied medicines in history," with evidence regarding its use during pregnancy being "continuously evaluated by the FDA for more than a decade."

It further claimed that available evidence does not support "a causal association between acetaminophen use in pregnancy and neurodevelopmental disorders, including ASD and ADHD."

RELATED: Tylenol's concerns about possible autism risk date back more than a decade, documents reportedly show

Billion-dollar brand

CNN reported that Tylenol generates about $1 billion annually for Kenvue and is considered to be its top-selling brand.

If the FDA agrees with ICAN's demand, Tylenol labels would need to be updated from its current instructions that say, "If pregnant or breast-feeding, ask a health professional before use."

President Trump had previously said during a press conference in September that if used during pregnancy, Tylenol was linked to a "very increased risk of autism."

"Fight like hell not to take it," Trump added.

RELATED: 'TrumpRx' website to offer discounted drugs as part of landmark Big Pharma deal

Photo by Jordan Bank/NWSL via Getty Images

New autism drug

At the same time, the U.S. Food and Drug Administration had begun its process to approve a treatment for autism-related symptoms.

The FDA announced in late September that it had approved leucovorin calcium tablets for patients with "cerebral folate deficiency."

The neurological condition affects folate transfer into the brain, the FDA said, adding that "individuals with cerebral folate deficiency have been observed to have developmental delays with autistic features."

"We have witnessed a tragic four-fold increase in autism over two decades," said FDA Commissioner Marty Makary. "Children are suffering and deserve access to potential treatments that have shown promise. We are using gold standard science and common sense to deliver for the American people."

According to the Mayo Clinic, leucovorin has a few side effects, all of which are listed as rare. These include skin rash, hives or itching, and wheezing. "Convulsions (seizures)" are also listed.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

After Leftist Smear Campaign, Northern MI University Bypasses Strong Presidential Candidate

America’s universities will fail to succeed unless they choose leaders based on who is the most qualified candidate and who is best equipped to lead the university into a promising future — regardless of leftist attacks.

Cartels are now ‘unlawful combatants.’ About time.



President Donald Trump has finally named the enemy: Mexican drug cartels. Declaring them unlawful combatants and recognizing a “non-international armed conflict” marks one of the most consequential national security shifts in modern history.

For decades, Washington treated cartel violence as a crime — a problem for prosecutors, not generals. Indictments were filed, assets seized, and sanctions imposed. But the cartels fought a different kind of war, one that combined terror, intelligence, and territorial control. Calling it “crime” guaranteed defeat.

We refused to define the cartels as belligerents — and fought the wrong fight.

According to the Armed Conflict Location and Event Data Project, Mexico ranks among the world’s most violent conflict zones — behind only Palestine, Myanmar, and Syria. It is also the second-most dangerous country for civilians. Those numbers are not from a failed state overseas. They come from our southern border, where cartel wars spill into American communities daily.

The old paradigm failed

For decades, federal authorities insisted on using a law-enforcement lens. Agencies operated under Title 21, Title 50, and limited “detect and monitor authorities. They punished crimes but never broke campaigns. The narrow scope bred strategic blindness. While U.S. prosecutors filed indictments and built cases, cartels corrupted institutions, coerced populations, and built empires.

As the Marine Corps teaches: How you define the environment determines how you operate in it. We refused to define the cartels as belligerents — and fought the wrong fight.

Hybrid belligerents, not gangs

By every operational measure, cartels are hybrid threats. They control territory, command loyalty through terror, and run parallel governments. They tax, adjudicate, and even “protect” local populations. Their power rests on corruption and espionage: bribing officials, infiltrating agencies, and compromising law enforcement through human networks that resemble intelligence tradecraft.

Cartels operate across land, air, maritime, subterranean, cyber, and electromagnetic domains. They deploy drones, tunnels, jammers, and encrypted systems. They are multi-domain actors running hybrid campaigns.

Weaponized migration

Cartels don’t just smuggle — they destabilize. Mass migration has become a weapon of war: overwhelming institutions, hiding operatives, and masking foreign infiltration. Millions of illegal entrants from more than 170 nations have crossed under cartel supervision. The intent is not just profit. It’s demographic disruption.

Under federal law, terrorism includes violence intended “to intimidate or coerce a civilian population” or “influence government policy.” By that definition, Sinaloa and Jalisco New Generation qualify as terrorist organizations.

A war of sovereignty

At the Texas Public Policy Foundation, I have testified before the Texas legislature and the U.S. Congress, warning that Mexico’s cartel conflict meets the Geneva Convention’s definition of a “non-international armed conflict.”

I described cartels as hybrid insurgents — foreign terrorist organizations that combine paramilitary violence, illicit economies, and political corruption to dominate populations. In March 2025 testimony, I stated plainly:

Mexico today is more accurately described as a state where governance has collapsed in key regions and foreign terrorist organizations dominate political and economic life, much like Afghanistan.

The president’s declaration confirms what many of us have argued for years: This is not a border problem — it is a war of sovereignty.

Against global networks

Cartel operations now span 65 countries. Chinese networks provide chemical precursors and launder money. Hezbollah and Iranian agents exploit the same smuggling corridors. Russia and Venezuela supply logistics and protection. Europol has confirmed joint cartel-European production of methamphetamine and cocaine. This is global insurgency — hybrid warfare waged through proxies.

The Western Hemisphere’s stability now hangs on whether the United States accepts that this is a war, not a criminal nuisance.

America has seen this pattern before. In Afghanistan, we failed not because we lacked strength but because we enabled corruption. We funded partners already captured by our enemies. The special inspector general for Afghanistan reconstruction documented how U.S. aid sustained the very system it sought to reform.

The parallels with Mexico and Venezuela are striking. Elements of their governments shelter cartels through impunity and contracts. Continuing to fund or legitimize such partners would repeat the Afghan mistake — this time on our own doorstep.

The new designation’s power

Trump’s declaration resets U.S. strategy. Recognizing cartels as unlawful combatants unlocks interagency coordination — treasury targeting financial networks, the IRS auditing tax-exempt fronts, and the Justice Department prosecuting to the “maximum extent permissible by law.” It is a full-spectrum approach that finally matches the enemy’s scale.

RELATED: Latin American leaders react to report that Trump will use US military against cartels

Photo by David Dee Delgado/Bloomberg via Getty Images

The new framework clarifies rules of engagement and intelligence sharing. We can now strike at the networks themselves, not just their accountants.

The cartels serve as convenient cutouts for America’s adversaries. China supplies chemicals, Iran and Hezbollah move cargo, Russia and Venezuela launder proceeds. These regimes use cartels as proxy forces — deniable, flexible, and brutal. The Western Hemisphere’s stability now hangs on whether the United States accepts that this is a war, not a criminal nuisance.

Peace through strength revisited

With this declaration, Trump restores the Reagan principle: peace through strength. As Secretary of War Pete Hegseth put it last week, “Our number-one job is to be strong so that we can prevent war in the first place.” Matching threats with capabilities sends a message not just to cartels, but to the nations behind them: Challenge us, and you will lose.

To borrow Hegseth’s phrasing: “Should our enemies choose foolishly to test us, they will be crushed by the violence, precision, and ferocity of the War Department. In other words, to our enemies: FAFO.”

The war has been declared. The only question now is whether America has the will to win it. State legislatures, Congress, and the public must rally behind this strategy. Half-measures have failed. The moment demands unity, clarity, and resolve.

America is under attack. The commander in chief has drawn the line. Now the nation must stand behind it — and fight to victory.